Driehaus Capital Management’s ANI Pharmaceuticals ANIP Stock Holding History

Driehaus Capital Management’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$9.34M	Buy	121,459 +45,279	+59%	+$3.53M	0.07%	272
2025 Q4	$6.01M	Sell	76,180 -2,634	-3%	-$228K	0.04%	299
2025 Q3	$7.22M	Buy	+78,814	New	+$6.43M	0.05%	307
2018 Q1	–	Sell	-3,414	Closed	-$220K	–	489
2017 Q4	$220K	Buy	+3,414	New	+$212K	0.01%	503
2016 Q4	–	Sell	-3,160	Closed	-$210K	–	526
2016 Q3	$210K	Buy	+3,160	New	+$198K	0.01%	474
2015 Q2	–	Sell	-57,123	Closed	-$3.57M	–	516
2015 Q1	$3.57M	Buy	57,123 +14,505	+34%	+$882K	0.12%	205
2014 Q4	$2.4M	Sell	42,618 -121,269	-74%	-$5.35M	0.1%	272
2014 Q3	$4.63M	Sell	163,887 -65,832	-29%	-$1.97M	0.18%	161
2014 Q2	$7.91M	Buy	229,719 +96,203	+72%	+$3.02M	0.26%	98
2014 Q1	$4.19M	Buy	+133,516	New	+$3.54M	0.13%	197

Other funds holding ANIP

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

SCM

Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $1.97B AUM 125.1% 1-Year Est. Return

GAM

Goldentree Asset Management New York $1.69B AUM 10.69% 1-Year Est. Return

DTC

Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Driehaus Capital Management's ANIP Position: Q1 2026 in Review

Driehaus Capital Management increased its ANI Pharmaceuticals (ANIP) stake by 59% in Q1 2026, buying an estimated $3.53M and bringing the position to 121,459 shares worth $9.34M. The position accounts for 0.07% of the portfolio, ranked #272.

Driehaus Capital Management first reported a position in ANIP in Q1 2014 and has held it in 10 quarters since. 280 funds tracked by Wall St. Rank hold ANIP as of Q1 2026.

Driehaus Capital Management held 121,459 shares of ANI Pharmaceuticals worth $9.34M as of Q1 2026.
Driehaus Capital Management bought 45,279 ANI Pharmaceuticals shares in Q1 2026, an estimated $3.53M.
ANI Pharmaceuticals made up 0.07% of Driehaus Capital Management's portfolio in Q1 2026, its #272 holding.
Driehaus Capital Management first reported a position in ANI Pharmaceuticals in Q1 2014 and has held it in 10 quarters since.
280 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q1 2026.

Based on Driehaus Capital Management's 13F filing for Q1 2026, filed 15 May 2026.